Key facts
- Operator of a digital health company intended to connect oncology care teams with patients.
- It has raised $80.8M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include La French Tech, Picus Capital, Cathay Innovation, Seaya Ventures, Xavier Niel — 19 tracked in total.
- 1 investment vehicle was formed to buy Resilience shares in the last 12 months, reporting $500K sold to 1 investors, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list: 19 names
- ·Watch Resilience: the Monday email on marks, rounds and moves
Funding rounds
No funding rounds for Resilience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Resilience shares, reporting $500K sold to 1 investors. Most recent filing Apr 2026.
About Resilience
Operator of a digital health company intended to connect oncology care teams with patients. The company's platform offers remote monitoring to track progress, manage adherence, and gather clinical data, alongside a mobile application for personalized support, education, and symptom tracking, enabling doctors to make informed decisions and individuals to enhance their well-being.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2021
- Employees
- 200
- Website
- resilience.care/
- Ownership
- Privately Held (backing)
Resilience doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.